Population based estimates of comorbidities affecting risk for complications from COVID-19 in the US

Mary L Adams; David L Katz; Joseph Grandpre

The copyright holder for this preprint (which was not peer-reviewed) is the The key variable was a composite measure including adults reporting they were ever told 67 they had cardiovascular disease (CVD: a heart attack, angina, coronary heart disease, or a 68 stroke), diabetes, current asthma (included as a chronic respiratory disease (2)), chronic 69 obstructive pulmonary disease (COPD), hypertension, and/ or cancer other than skin. The author/funder, who has granted medRxiv a license to display the preprint in perpetuity. We also used available case fatality rates from China (3) to estimate the fraction of adults 93 in that country with any of the 6 comorbid conditions. We used the formula below and different 94 estimates of the CFR for adults with at least one of the comorbid conditions, ranging from 7.6% -95 13.2%, including 9.28% which was the average, and 8.4% which is the rate for hypertension, the 96 most prevalent comorbid condition (3); 1.4% was the CFR for those with none of the 6 and 3.8% author/funder, who has granted medRxiv a license to display the preprint in perpetuity.